0001712617-17-000001.txt : 20170726 0001712617-17-000001.hdr.sgml : 20170726 20170726143046 ACCESSION NUMBER: 0001712617-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170726 DATE AS OF CHANGE: 20170726 EFFECTIVENESS DATE: 20170726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orbsen Therapeutics Ltd. CENTRAL INDEX KEY: 0001712617 IRS NUMBER: 981377779 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291532 FILM NUMBER: 17982444 BUSINESS ADDRESS: STREET 1: ORBSEN BUILDING STREET 2: NATIONAL UNIVERSITY OF IRELAND, GALWAY CITY: GALWAY STATE: L2 ZIP: H91DK59 BUSINESS PHONE: 353 91 528778 MAIL ADDRESS: STREET 1: ORBSEN BUILDING STREET 2: NATIONAL UNIVERSITY OF IRELAND, GALWAY CITY: GALWAY STATE: L2 ZIP: H91DK59 D 1 primary_doc.xml X0708 D LIVE 0001712617 Orbsen Therapeutics Ltd. ORBSEN BUILDING NATIONAL UNIVERSITY OF IRELAND, GALWAY GALWAY L2 IRELAND H91DK59 353 91 528778 IRELAND Pro-Cure Laboratories Limited None Limited Liability Company true Larry Couture c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Executive Officer Director Jack Kavanaugh c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Director Chris Coughlan c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Director Jim Fahy c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Director Francis Barry c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Executive Officer Director Timothy O'Brien c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Director Gerry Cuddy c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Director Scott Tornblom c/o Orbsen Therapeutics Ltd. Orbsen Bldg., National Univ of Ireland Galway L2 IRELAND H91DK59 Director Biotechnology Decline to Disclose 06b false 2017-01-19 false true false 50000 3690600 1257491 2433109 All USD amounts calculated using average conversion rate of GBP at initial closing. false 11 0 0 0 false Orbsen Therapeutics Ltd. /s/ Larry A. Couture Larry A. Couture Chief Executive Officer 2017-07-26